{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T03:59:13Z","timestamp":1754193553306,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004687","name":"Universidad de Murcia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004687","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Some procedures performed during cytoreductive surgery (CRS) and hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) are based on empirical data. One of these procedures is systematic cholecystectomy. This study aimed to perform a critical analysis of the need for systematic cholecystectomy during CRS+HIPEC of patients with peritoneal carcinomatosis using long-term follow-up data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with peritoneal surface malignancies who were candidates for CRS+HIPEC and underwent surgery between January 2008 and December 2022 were analyzed. For patients with gallbladder involvement due to the disease or for patients whose preoperative study showed the presence of cholelithiasis, cholecystectomy was performed as part of the surgery, which was avoided for the remaining patients. All postoperative adverse events that occurred in the first 90 days were recorded, and clinical records focused on the development of biliary pathology during the follow-up period were studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results from a consecutive series of 443 patients with peritoneal surface malignancies who underwent surgery between January 2008 and December 2022 were analyzed. The average age of the cohort was 50 years. The median follow-up period for the cohort was 41 months (range, 12\u2013180 months), with a disease-free survival of 17 months. For 373 of the patients, CRS+HIPEC was completed without an associated cholecystectomy, and in 16 of them, the appearance of cholelithiasis was detected during the follow-up period. Only two patients in the series showed complications derived from gallstones and required a delayed cholecystectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although cholecystectomy is a safe procedure in the context of CRS+HIPEC, it is not risk free, and its routine performance may be unnecessary.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-15863-z","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:03:43Z","timestamp":1722035023000},"page":"7157-7164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition"],"prefix":"10.1245","volume":"31","author":[{"given":"Alida","family":"Gonzalez-Gil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro Jes\u00fas","family":"Gomez-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gonzalez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gil-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Olivares-Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer\u00f3nimo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Barcel\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Antonio","family":"Cascales-Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"15863_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.06.007","volume":"48","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev. 2016;48:42\u20139.","journal-title":"Cancer Treat Rev."},{"key":"15863_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, Bhatt A, Ceelen W, Glehen O, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7:91.","journal-title":"Nat Rev Dis Primers."},{"key":"15863_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin North Am. 2003;12:703\u201327.","journal-title":"Surg Oncol Clin North Am."},{"key":"15863_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69\u201376.","journal-title":"Lancet Oncol."},{"key":"15863_CR5","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1245\/s10434-023-13973-8","volume":"30","author":"V Kepenekian","year":"2023","unstructured":"Kepenekian V, Sgarbura O, Marchal F, Villeneuve L, Kusamura S, Deraco M. 2022 PSOGI consensus on HIPEC regimens for peritoneal malignancies: diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2023;30:7803\u201313.","journal-title":"Ann Surg Oncol."},{"key":"15863_CR6","doi-asserted-by":"crossref","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, UNICANCER-GI Group and BIG Renape Group, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366","DOI":"10.1016\/S1470-2045(20)30599-4"},{"key":"15863_CR7","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Rihuete Caro C, P\u00e9rez-Viejo E, Serrano \u00c1, Guti\u00e9rrez Calvo A, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol. 2019;26:2615\u201321.","journal-title":"Ann Surg Oncol."},{"key":"15863_CR8","doi-asserted-by":"crossref","unstructured":"van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, et al. (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 378:230\u201340","DOI":"10.1056\/NEJMoa1708618"},{"key":"15863_CR9","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1245\/s10434-021-11087-7","volume":"29","author":"CCP Antonio","year":"2022","unstructured":"Antonio CCP, Alida GG, Elena GG, Roc\u00edo GS, Jer\u00f3nimo MG, Luis ARJ, et al. Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial. Ann Surg Oncol. 2022;29:2617\u201325.","journal-title":"Ann Surg Oncol."},{"key":"15863_CR10","doi-asserted-by":"crossref","unstructured":"Lim MC, Chang SJ, Park B, Yoo HJ, Yoo CW, Nam BH, Park SY, HIPEC for Ovarian Cancer Collaborators. Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial. JAMA Surg. 2022;157:374\u201383.","DOI":"10.1001\/jamasurg.2022.0143"},{"key":"15863_CR11","doi-asserted-by":"publisher","first-page":"100586","DOI":"10.1016\/j.esmoop.2022.100586","volume":"7","author":"P Filis","year":"2022","unstructured":"Filis P, Mauri D, Markozannes G, Tolia M, Filis N, Tsilidis K. Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials. ESMO Open. 2022;7:100586.","journal-title":"ESMO Open."},{"key":"15863_CR12","doi-asserted-by":"crossref","unstructured":"Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, OVHIPEC-2 Steering Committee and the Dutch OVHIPEC Group, et al. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Int J Gynecol Cancer. 2020;30:888\u201392.","DOI":"10.1136\/ijgc-2020-001231"},{"key":"15863_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg."},{"key":"15863_CR14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/00031348241246171","volume":"90","author":"A Mina","year":"2024","unstructured":"Mina A, Bailey CE, Cohen N, Labow D, Golas B, Sarpel U, Idrees K, Magge D. Prophylactic Cholecystectomy is safe in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am Surg. 2024;90:1577\u201381.","journal-title":"Am Surg."},{"key":"15863_CR15","doi-asserted-by":"crossref","unstructured":"Parrilla P, Robles R, Varo E, Jim\u00e9nez C, S\u00e1nchez-Cab\u00fas S, Pareja E, Spanish Liver Transplantation Study Group. Liver transplantation for bile duct injury after open and laparoscopic cholecystectomy. Br J Surg. 2014;101:63\u20138","DOI":"10.1002\/bjs.9349"},{"key":"15863_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ciresp.2016.05.023","volume":"94","author":"V Soria-Aledo","year":"2016","unstructured":"Soria-Aledo V, Romero Sim\u00f3 M, Balibrea JM, Badia JM. Recommendations of \u201cnot-to-do\u201d: proposals of the Spanish Association of Surgeons to the project \u201cCommitment to Quality of Scientific Societies.\u201d Cir Esp. 2016;94:453\u20139.","journal-title":"Cir Esp."},{"key":"15863_CR17","doi-asserted-by":"crossref","unstructured":"Hassan S, Dritsas S, O\u2019Dwyer ST, Aziz O, Sutton P, Wang X, Fish R; other members of the Colorectal and Peritoneal Oncology Group. Open versus closed technique for administration of heated intraperitoneal chemotherapy (HIPEC): morbidity and mortality outcomes from a high-volume centre. Eur J Surg Oncol. 2023;49:106924.","DOI":"10.1016\/j.ejso.2023.04.023"},{"key":"15863_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1245\/s10434-021-10661-3","volume":"29","author":"SP Somashekhar","year":"2022","unstructured":"Somashekhar SP, Rohit KC, Ramya Y, Zaveri SS, Ahuja V, Namachivayam AK, Ashwin KR. Bowel anastomosis after or before HIPEC: a comparative study in patients undergoing CRS+HIPEC for peritoneal surface malignancy. Ann Surg Oncol. 2022;29:214\u201323.","journal-title":"Ann Surg Oncol."},{"key":"15863_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s12094-019-02195-8","volume":"22","author":"P Cascales Campos","year":"2020","unstructured":"Cascales Campos P, Martinez Insfran LA, Wallace D, Gil J, Gil E, Gonzalez Gil A, et al. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. Clin Transl Oncol. 2020;22:852\u20139.","journal-title":"Clin Transl Oncol."},{"key":"15863_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02470844","volume":"18","author":"T Inoue","year":"1988","unstructured":"Inoue T, Mishima Y. Postoperative acute cholecystitis: a collective review of 494 cases in Japan. Jpn J Surg. 1988;18:35\u201342.","journal-title":"Jpn J Surg."},{"key":"15863_CR21","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1245\/s10434-022-12792-7","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Qi X, Zhou H, Ju M, Wang R, Li K, et al. Individualized choice of simultaneous cholecystectomy in patients with gastric cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2023;30:1744\u201354.","journal-title":"Ann Surg Oncol."},{"key":"15863_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/00015458.2018.1554364","volume":"120","author":"F Cavallin","year":"2020","unstructured":"Cavallin F, Scarpa M, Cagol M, Alfieri R, Ruol A, Chiarion Sileni V, et al. Cholecystectomy during esophagectomy is safe but unnecessary. Acta Chir Belg. 2020;120:35\u201341.","journal-title":"Acta Chir Belg."},{"key":"15863_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/gyn.1990.6.195","volume":"6","author":"JH Malfetano","year":"1990","unstructured":"Malfetano JH, MacDowell RT, O\u2019Hare MM. Incidental cholecystectomy in the treatment of gynecologic malignancy. J Gynecol Surg. 1990;6:195\u20138.","journal-title":"J Gynecol Surg."},{"key":"15863_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11695-021-05798-9","volume":"32","author":"REA Allatif","year":"2022","unstructured":"Allatif REA, Mannaerts GHH, Al Afari HST, Hammo AN, Al Blooshi MS, Bekdache OA, et al. Concomitant cholecystectomy for asymptomatic gallstones in bariatric surgery-safety profile and feasibility in a large tertiary referral bariatric center. Obes Surg. 2022;32:295\u2013301.","journal-title":"Obes Surg."},{"key":"15863_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0002-9610(05)80930-4","volume":"165","author":"GD Friedman","year":"1993","unstructured":"Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993;165:399\u2013404.","journal-title":"Am J Surg."},{"key":"15863_CR26","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1002\/cncr.23961","volume":"113","author":"RW Thomsen","year":"2008","unstructured":"Thomsen RW, Thomsen HF, N\u00f8rgaard M, Cetin K, McLaughlin JK, Tarone RE, et al. Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark. Cancer. 2008;113:3410\u20139.","journal-title":"Cancer."},{"key":"15863_CR27","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s10620-007-9989-8","volume":"53","author":"M Fein","year":"2008","unstructured":"Fein M, Bueter M, Sailer M, Fuchs KH. Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms. Dig Dis Sci. 2008;53:1186\u201391.","journal-title":"Dig Dis Sci."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15863-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15863-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15863-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:29:31Z","timestamp":1726756171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15863-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15863"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15863-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}